BN 52021: a platelet activating factor antagonist for preventing post-transplant renal failure. A double-blind, randomized study. The BN 52021 Study Group in Renal Transplantation

Ann Intern Med. 1994 Sep 1;121(5):345-7. doi: 10.7326/0003-4819-121-5-199409010-00006.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Cadaver
  • Diterpenes*
  • Double-Blind Method
  • Female
  • Ginkgolides
  • Humans
  • Kidney Transplantation / adverse effects*
  • Lactones / therapeutic use*
  • Male
  • Middle Aged
  • Pilot Projects
  • Platelet Activating Factor / antagonists & inhibitors*
  • Renal Insufficiency / etiology
  • Renal Insufficiency / prevention & control*

Substances

  • Diterpenes
  • Ginkgolides
  • Lactones
  • Platelet Activating Factor
  • ginkgolide B